Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.

Titled, “New chapter unfolding in the fight against dengue with an unwritten ending,” the Dengue Vaccine Initiative’s (DVI) editorial just published in the October issue of Transactions

Pages